A research exhibition titled 'Poster Presentations' was organized late Tuesday at the Central Library of Allama Iqbal Open ...

The Kalaburagi Regional Centre of Karnataka State Council of Science and Technology (KSCST), in collaboration with the ...

The Heartscape'25 was organized by the unit of cardiovascular and perfusion technology, Yenepoya School of Allied Health ...

Misericordia University celebrated the accomplishments of the Misericordia University nursing department’s part-time evening ...

Enrollment in RAPIDe-3, the pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, continuing as planned; topline data anticipated in 1Q2026 Study initiation of ...

Over 200 delegates from more than 100 institutes across India and abroad convened on Wednesday atIIT ISM to participate in the 24th National Conference on  Atomic and Molecular Physics (NCAMP 2025).

Initiated CHAPTER-3, the pivotal Phase 3 study of deucrictibant for prophylaxis against hereditary angioedema (HAE) attacks in 2024; topline data anticipated in 2H2026Enrollment in RAPIDe-3, the pivot ...

Allergy and immunology lost a pioneer last summer with the death of Marcus Maurer, MD, executive director of the Institute of Allergology at Charité University Medicine, Berlin. Maurer was an author ...

Further expanding on the theme, a film festival will be hosted on Feb. 9 that will feature short films from around the world ...

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in treatment ...

DBV Technologies (DBVT) announced twenty-four month results from its Open-Label Extension Study of EPITOPE. The data provide support that ...